PRMT5 and neoplasm: PRMT5‐mediated methylation suppressed the autophosphorylation and kinase activity of Hippo pathway initiator MST2, resulting in the inactivation of the tumor suppressor pathway Hippo signaling axis and progression in pancreatic cancer [12].